USFDA approves Alembic Pharma gets for Darifenacin tablets

As per the new study, USFDA approves Alembic Pharmaceuticals research and development Pharma Company received for Darifenacin extended-release tablets for the treatment of an overactive bladder.

“We have received approval from the US Food and Drug Administration (USFDA) for our abbreviated new drug application (ANDA) Darifenacin extended-release tablets, 7.5 mg and 15 mg.

An organization statement said here, the approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Enablex extended-release tablets, 7.5 mg and 15 mg of Allergan Pharmaceuticals,”.

BARC India elects Nakul Chopra as Chairman. Mumbai, Dec 12 Television rating office Broadcast Audience Research Council (BARC) India today said it has elected Publicis Communications’ Senior Advisor Nakul Chopra as Chairman.

Chopra, who succeeds Viacom18 Group Chief Executive Officer Sudhanshu Vats, is currently the President of Advertising Agencies Association of India (AAAI).

He will be the third Chairman of BARC India and joined the BARC India Board in September 2016. Subhash Chandra launches accelerator to guide Start-ups.

Essel Group chairman and Rajyasabha MP Subhash Chandra have declared the launch of an accelerator program – Accelerator to guide new companies in media, entertainment, media technology and educational technology sectors.

Chandra had launched a foundation and pledged Rs 5000 crore of his family wealth towards generous initiatives of the Foundation.

This initiative will be facilitated through the foundation, a statement stated here. The program will be controlled by TiE Mumbai, a non- profit worldwide community.

The program plans to co-develop and nurture early and development stage startups that can possibly develop into effective companies later on.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

12 + twelve =